News
Merck KGa A and Remepy join forces to develop combo drug-digital therapies
51+ min ago (551+ words) Merck KGa A has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and app-based approaches in rare oncology " marking the first big pharma foray into this new evolving area for digital therapies....
Tandem secures FDA approval for Control-IQ+ use in pregnancy
2+ hour, 3+ min ago (319+ words) The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025. Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated insulin delivery technology to be used during…...
Nervonik closes $52. 5m Series B funding to advance PNS system
3+ hour, 26+ min ago (228+ words) The funds will support further development of Nervonik's sensing technology and commercialisation of its PNS platform. US-based medical device company Nervonik has secured $52. 5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system. Amzak Health led the…...
Motif Neurotech secures FDA IDE to initiate depression implant study
21+ hour, 46+ min ago (386+ words) Motif's study primarily aims to validate the safety of its XCS system over a 12-month period following implantation. The US Food and Drug Administration (FDA) has granted Motif Neurotech an investigational device exemption (IDE) to initiate a study to evaluate…...
Types of drinks - latest news, analysis and updates on Drinks
3+ mon, 1+ week ago (174+ words) Abbott has gained a CE mark in the European Union (EU) for the Tacti Flex Duo ablation catheter, representing the company's latest addition to its growing pulsed-field ablation (PFA) portfolio for atrial fibrillation (AFib) treatment....
J&J agrees to acquire Atraverse Medical to advance cardiac ablation portfolio
1+ day, 1+ hour ago (436+ words) Should the transaction complete, J&J will inherit Atraverse's radiofrequency system for simplifying access to the heart's left atrium. Johnson & Johnson (J&J) has agreed to acquire Atraverse Medical in a development that will give the medtech giant a left atrium…...
Adagio Medical reports positive six-month results in FULCRUM-VT trial
1+ day, 2+ hour ago (307+ words) Adagio Medical has reported positive six-month data from its pivotal FULCRUM-VT trial, supporting its plans to seek premarket approval from the US Food and Drug Administration (FDA) for the v CLAS ventricular ablation system. It also reported a 2. 4% rate of…...
Brio Health secures FDA approval to launch Brio VAD system trial
1+ day, 3+ hour ago (284+ words) Brio Health Solutions has secured conditional approval from the US Food and Drug Administration (FDA) to initiate a clinical trial of its Brio VAD system in children diagnosed with advanced heart failure. The Brio4 Kids trial will proceed under the company's…...
First patient dosed in GE Health Care's Phase II/III LUMINA clinical trial
4+ day, 2+ hour ago (435+ words) Mangaciclanol's Phase I trial showed it was well tolerated, with no serious adverse events or clinically significant findings. GE Health Care has dosed the first patient in its international, multi-centre Phase II/III LUMINA clinical trial for the investigational manganese-based…...
GE and Deep Health expand partnership for breast screening solutions
1+ week, 4+ day ago (247+ words) The agreement builds upon a 2024 collaboration integrating Deep Health's AI workflow with GE Health Care's Senographe system. GE Health Care has expanded its partnership with Rad Net subsidiary Deep Health to broaden access to AI-powered breast cancer screening solutions. The…...